Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Carcinoma to the Uterine Cervix”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07266350
What this trial is testing

A Non-interventional Registration Study of Monotherapy or Combination Regimens Based on Camrelizumab or Famitinib for the Treatment of Cervical Cancer

Who this might be right for
Cervical Cancer MetastaticCervical Cancer Recurrent
Qi Zhou 1,300
Testing effectiveness (Phase 2)UnknownNCT05824494
What this trial is testing

Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors

Who this might be right for
Uterine Cervical NeoplasmsCancer of CervixCervical Cancer+3 more
Women's Hospital School Of Medicine Zhejiang University 58
Not applicableNot Yet RecruitingNCT07652983
What this trial is testing

TTE Study of QL1706 in Recurrent/Metastatic Cervical Cancer

Who this might be right for
Recurrent or Metastatic Cervical Cancer
Qilu Hospital of Shandong University 280
Testing effectiveness (Phase 2)Study completedNCT04205799
What this trial is testing

Cabozantinib for Advanced or Metastatic Cervical Carcinoma After Platinum Treatment Failure

Who this might be right for
Advanced/Metastatic Cervical Cancer
Centre Francois Baclesse 57
Testing effectiveness (Phase 2)Study completedNCT04693234
What this trial is testing

AdvanTIG-202: Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Previously Treated Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
BeiGene 178
Testing effectiveness (Phase 2)Active Not RecruitingNCT03614949
What this trial is testing

SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

Who this might be right for
Cervical CancerCervical Cancer RecurrentCervical Cancer Metastatic
H. Lee Moffitt Cancer Center and Research Institute 21
Not applicableLooking for participantsNCT03010150
What this trial is testing

Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer

Who this might be right for
Carcinoma of Unknown PrimaryClinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+28 more
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT06123884
What this trial is testing

BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer

Who this might be right for
Cervical Cancer
Bio-Thera Solutions 526
Not applicableLooking for participantsNCT06771193
What this trial is testing

Study on Disease Characteristics and Treatment in Locally Advanced or Recurrent / Metastatic Cervical Cancer in Italy

Who this might be right for
Cervical CancerLocally Advanced Cervical CancerRecurrent Cervical Cancer+1 more
MSD Italia S.r.l. 200
Testing effectiveness (Phase 2)UnknownNCT04884906
What this trial is testing

Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer

Who this might be right for
Locally Advanced Cervical Cancer
Tianjin Medical University Cancer Institute and Hospital 40
Large-scale testing (Phase 3)Study completedNCT04697628
What this trial is testing

Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Seagen, a wholly owned subsidiary of Pfizer 502
Testing effectiveness (Phase 2)UnknownNCT03808857
What this trial is testing

A Study in Recurrent or Metastatic Cervical Cancer Patients With PD-L1 Positive

Who this might be right for
Cervical Cancer
Genor Biopharma Co., Ltd. 80
Not applicableStudy completedNCT06313268
What this trial is testing

Safety of Effivia®, a Bevacizumab Biosimilar

Who this might be right for
Metastatic Colorectal CancerMetastatic Cervical CancerNon Squamous Non Small Cell Lung Cancer
Laboratorios Liomont 83
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07627620
What this trial is testing

Camrelizumab Combined With Famitinib Malate and Chemotherapy for Treatment of Recurrent/ Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Hunan Cancer Hospital 54
Large-scale testing (Phase 3)UnknownNCT05715840
What this trial is testing

Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)

Who this might be right for
Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 368
Testing effectiveness (Phase 2)UnknownNCT02492503
What this trial is testing

Effectiveness of Chemotherapy in Metastatic or Recurrent Carcinoma Cervix

Who this might be right for
Metastatic Carcinoma to the Uterine CervixRecurrent Carcinoma CervixCervix Carcinoma Recurrent
All India Institute of Medical Sciences 40
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Large-scale testing (Phase 3)Not Yet RecruitingNCT07392060
What this trial is testing

A Phase III Clinical Study of WX390 Combined With Toripalimab Versus Investigator's Choice of Therapy in Patients With Recurrent or Metastatic Cervical Cancer Who Have Failed Prior Platinum-Based Treatment

Who this might be right for
Cervical Cancer Metastatic
Shanghai Jiatan Pharmatech Co., Ltd 440
Testing effectiveness (Phase 2)Looking for participantsNCT06859775
What this trial is testing

SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer

Who this might be right for
Recurrent or Metastatic Cervical Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT02257528
What this trial is testing

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaRecurrent Cervical Carcinoma+3 more
National Cancer Institute (NCI) 26
Next Page
471